Roivant Sciences Ltd. ( ROIV) - Key Metrics
ROIV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0 | -$0.38 | -$0.28 | -$0.27 |
| 2025Q2 | $0 | -$0.17 | -$0.27 | -$0.28 |
| 2025Q1 | $0 | -$0.33 | -$0.30 | -$0.31 |
| 2024Q4 | $0.01 | -$0.29 | -$0.24 | -$0.25 |
ROIV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -14.22 |
| 2025Q2 | ? | -22.69 |
| 2025Q1 | ? | -8.58 |
| 2024Q4 | ? | -8.64 |
ROIV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | -0.85% | ? |
| 2025Q3 | -1.27% | ? |
| 2025Q2 | -1.88% | ? |
| 2025Q1 | -2.72% | ? |
| 2024Q4 | -2.43% | ? |
ROIV
Price: $35.01
52 week price:
Earnings Per Share: -0.54 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 1.4 million
Market Capitalization: 25.8 billion